Skip to content

Effects of different doses of dexmedetomidine at different infusion rates on cardiac function and systemic vascular resistance in elderly patients

Effects of different doses of dexmedetomidine at different infusion rates on cardiac function and systemic vascular resistance in elderly patients

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040989
Enrollment
Unknown
Registered
2020-12-16
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

elderly patients

Interventions

Group O:control group
Group A:intravenous infusion of dexmedetomidine with a loading dose of 0.5 µg/kg within 10 minutes
Group B:intravenous infusion of dexmedetomidine with a loading dose of 0.5 µg/kg within 15 minutes
Group C:intravenous infusion of dexmedetomidine with a loading dose of 1.0µg/kg within 10 min
Group D:intravenous infusion of dexmedetomidine with a loading dose of 1.0µg/kg within 15 min

Sponsors

Jiangsu Province Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1 Aged 60-80 years old with ASA grade II-III, scheduled for elective surgery between Jan.2021- March 2021. 2 Weighted 45-75 kg, and BMI were between 19-24 kg/m2. 3 Physical examination Laboratory tests and health conditions were not abnormal, No signs of difficult airway; No history of mental illness. 4 Cognitive function was normal and MMSE score was higher than 27. 5 No abnormality in ST segment of ecg before operation.

Exclusion criteria

Exclusion criteria: 1 Severe arrhythmia, atrioventricular block, Abnormal liver function, Abnormal renal function, lung disease, endocrine disease, other diseases or pathological conditions that affect the test results. 2 Severe hearing and visual impairment, or other conditions that interfere with communication. 3 Prolonged use of sedatives, sleeping pills, and antidepressants. 4 History of cerebral infarction, central nervous system diseases, organic brain diseases, mental disorders. 5 Chronic coffee drinkers, addicted to alcohol or drugs. 6 Allergic to research drugs. 7 Secondary hypertension. 8 Significant pain before the operation (VASpain >= 3).

Design outcomes

Primary

MeasureTime frame
EF;SV;CO;CI;IVRT;E/A;DT;DT;SVRI;

Secondary

MeasureTime frame
Hemodynamic index;arterial blood gas analysis;

Countries

China

Contacts

Public ContactQian Yanning

Jiangsu Province Hospital

yanning_qian@163.com+86 13951701214

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026